Corporate publications

Terms of Reference and Rules of Procedure of the Audit and Risk Committee

PDF : 131 KB | 06/12/2023

Annual Report 2022

PDF : 6586 KB | 15/11/2023

Outcome – Public Consultation on proposed fees for Human Medicines, Compliance, Medical Devices and Veterinary Medicines for 2024 - November 2023

PDF : 101 KB | 10/11/2023

Public consultation – Proposed fees for 2024: Human Medicines, Compliance Activities, Blood, Tissue Establishments, Organs and Medical Devices - October 2023

PDF : 506 KB | 05/10/2023

Public consultation – Proposed fees for 2024: Veterinary Medicinal Products – October 2023

PDF : 190 KB | 05/10/2023

Outcome – Public Consultation on proposed Human Medicines, Compliance fees, Medical Device fees and Veterinary Medicines for 2023 - November 2022

PDF : 78 KB | 22/11/2022

Annual Report 2021

PDF : 1700 KB | 12/10/2022

Annual Report for 2021

Public consultation – Proposed fees for 2023: Veterinary Medicinal Products – October 2022

PDF : 330 KB | 10/10/2022

HPRA Patient Forum - Consideration of potential conflicts of interests

PDF : 86 KB | 13/09/2022

Annual Report 2020

PDF : 8781 KB | 28/11/2021

Annual report for 2020

Strategic Plan 2021 – 2025

PDF : 7214 KB | 01/06/2021

Terms of Reference and Rules of Procedure of the HPRA

PDF : 175 KB | 21/08/2015

Terms of Reference and Rules of Procedure of the Committee for Scientific Animal Protection Appeals

PDF : 151 KB | 16/07/2014

Terms of Reference and Rules of Procedure of the Advisory Committee for Medical Devices

PDF : 122 KB | 27/06/2014

Terms of Reference and Rules of Procedure of the Advisory Committee for Veterinary Medicines

PDF : 130 KB | 27/06/2014

Terms of Reference and Rules of Procedure of the Advisory Committee for Human Medicines

PDF : 157 KB | 27/06/2014

Terms of Reference and Rules of Procedure of the Performance Review Committee